Literature DB >> 15543028

Sexual dysfunction in women with premature menopause.

Alessandra Graziottin1, Rosemary Basson.   

Abstract

OBJECTIVE: To discuss assessment and management of sexual dysfunctions associated with premature menopause.
DESIGN: Literature review plus clinical observations.
RESULTS: Studies on assessment and management of sexual dysfunctions associated with premature menopause are minimal. Premature menopause affects sexual identity, sexual function, and sexual relationship. Major modulating factors include etiology, life cycle stage, factors personal to the woman, and family and societal influences. Loss of ovarian function in adolescence may delay psychosexual maturity via psychological and biological mechanisms. Maternity becomes impossible, unless ovodonation is feasible, accepted, and legally available. Loss of sexual desire, subjective and genital arousal, and orgasm may be highly distressing. Reduction of sex hormones and psychological reactions of both partners to the prematurity and infertility are etiologically important. Estrogen therapy is usually indicated, but long-term safety data in this population are lacking. Testosterone therapy, also lacking in safety data and mainly investigational, may be needed to restore sexual arousability. Presence, age, and sexual health of the partner, having children, and quality of intimacy in previous and present relationships modulate coping attitudes and clinical outcome.
CONCLUSIONS: An interdisciplinary medical and psychosexual approach comprises individualized hormone therapy and specific psychosexual treatment(s). Research into optimal management of sexual dysfunction with premature menopause is urgently needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15543028     DOI: 10.1097/01.gme.0000139926.02689.a1

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  17 in total

Review 1.  Long-term health consequences of premature or early menopause and considerations for management.

Authors:  S S Faubion; C L Kuhle; L T Shuster; W A Rocca
Journal:  Climacteric       Date:  2015-04-07       Impact factor: 3.005

2.  Sexual health and rehabilitation after ovarian suppression treatment (SHARE-OS): a clinical intervention for young breast cancer survivors.

Authors:  Sharon L Bober; E Fine; C J Recklitis
Journal:  J Cancer Surviv       Date:  2019-09-03       Impact factor: 4.442

Review 3.  Hormone replacement therapy in young women with surgical primary ovarian insufficiency.

Authors:  Philip M Sarrel; Shannon D Sullivan; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2016-10-25       Impact factor: 7.329

Review 4.  Quality of life and gynecologic malignancies.

Authors:  Charlotte C Sun; Michael Frumovitz; Diane C Bodurka
Journal:  Curr Oncol Rep       Date:  2005-11       Impact factor: 5.075

Review 5.  Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.

Authors:  Shannon D Sullivan; Philip M Sarrel; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2016-12       Impact factor: 7.329

6.  A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer.

Authors:  Carolyn Y Fang; Carol Cherry; Karthik Devarajan; Tianyu Li; John Malick; Mary B Daly
Journal:  Gynecol Oncol       Date:  2009-01-13       Impact factor: 5.482

7.  Sexual function in young women with spontaneous 46,XX primary ovarian insufficiency.

Authors:  Sophia N Kalantaridou; Vien H Vanderhoof; Karim A Calis; Emily C Corrigan; James F Troendle; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2007-10-25       Impact factor: 7.329

8.  Research on the Effects of Alcohol and Sexual Arousal on Sexual Risk in Men who have Sex with Men: Implications for HIV Prevention Interventions.

Authors:  Stephen A Maisto; Jeffrey S Simons
Journal:  AIDS Behav       Date:  2016-01

Review 9.  Gynecologic cancers associated with Lynch syndrome/HNPCC.

Authors:  K M Schmeler; K H Lu
Journal:  Clin Transl Oncol       Date:  2008-06       Impact factor: 3.405

Review 10.  Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI).

Authors:  Bunpei Ishizuka
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.